The Herz und Diabeteszentrum, is a heart clinic in the German town Bad Oeynhausen. It is known for performing the most heart transplants in Europe.

There are 500 (2010) beds in Herz- und Diabeteszentrum NRW.

During the past decade, Herz- und Diabeteszentrum NRW conducted 106 clinical trials. In the 10-year time frame, 106 clinical trials started and 18 clinical trials were completed, i.e. on average, 17% percent of trials that started reached the finish line to date. In the past 5 years, 58 clinical trials started and 10 clinical trials were completed. i.e. 17.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Herz- und Diabeteszentrum NRW" #1 sponsor was "Heart and Diabetes Center North-Rhine Westfalia" with 17 trials, followed by "Abbott Medical Devices" with 14 trials sponsored, "Edwards Lifesciences" with 9 trials sponsored, "Biotronik SE & Co. KG" with 8 trials sponsored and "Boston Scientific Corporation" with 8 trials sponsored. Other sponsors include 103 different institutions and companies that sponsored additional 72 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Herz- und Diabeteszentrum NRW" #1 collaborator was "German Federal Ministry of Education and Research" with 8 trials as a collaborator, "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 7 trials as a collaborator, "Heart Center Leipzig - University Hospital" with 4 trials as a collaborator, "Heart and Diabetes Center North Rhine-Westphalia" with 3 trials as a collaborator and "Abbott" with 2 trials as a collaborator. Other collaborators include 70 different institutions and companies that were collaborators in the rest 73 trials.

According to Clinical.Site data, the most researched conditions in "Herz- und Diabeteszentrum NRW" are "Heart Failure" (26 trials), "Atrial Fibrillation" (14 trials), "Aortic Valve Stenosis" (11 trials), "Coronary Artery Disease" (10 trials) and "Mitral Regurgitation" (5 trials). Many other conditions were trialed in "Herz- und Diabeteszentrum NRW" in a lesser frequency.

Most popular intervention types in "Herz- und Diabeteszentrum NRW" are "Device" (79 trials), "Drug" (36 trials), "Procedure" (15 trials), "Other" (8 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Aspirin" (2 trials), "Boston Scientific Cardiac Cryoablation System" (2 trials), "Edwards PASCAL Transcatheter Valve Repair System" (2 trials) and "Empagliflozin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Herz- und Diabeteszentrum NRW" are 159 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 58 active trials in "Herz- und Diabeteszentrum NRW". 1 are not yet recruiting, 35 are recruiting, 21 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 79 completed trials in Herz- und Diabeteszentrum NRW, undefined suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Herz- und Diabeteszentrum NRW, 2 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 45 trials that are defined as “Not Applicable".

Herz- und Diabeteszentrum NRW has several departments that took part in Clinical trials: "Kardiologische Klinik Herz- und Diabeteszentrum" - 2 trials, "Herz- und Diabeteszentrum NRW, Klinik für Thorax- und Kardiovaskularchirurgie" - 2 trials